Y, S., J, W., H, S., M, O., M, M., A, I., . . . I, E. (2023). Exploratory randomized phase II trial for optimizing treatment dosage and duration of adjuvant S-1 plus oxaliplatin in patients with stage III colon cancer: YCOG1402 (SOAP trial). Annals of gastroenterological surgery, 7(6), 922. https://doi.org/10.1002/ags3.12687
Chicago Style (17th ed.) CitationY, Suwa, et al. "Exploratory Randomized Phase II Trial for Optimizing Treatment Dosage and Duration of Adjuvant S-1 Plus Oxaliplatin in Patients with Stage III Colon Cancer: YCOG1402 (SOAP Trial)." Annals of Gastroenterological Surgery 7, no. 6 (2023): 922. https://doi.org/10.1002/ags3.12687.
MLA (9th ed.) CitationY, Suwa, et al. "Exploratory Randomized Phase II Trial for Optimizing Treatment Dosage and Duration of Adjuvant S-1 Plus Oxaliplatin in Patients with Stage III Colon Cancer: YCOG1402 (SOAP Trial)." Annals of Gastroenterological Surgery, vol. 7, no. 6, 2023, p. 922, https://doi.org/10.1002/ags3.12687.